Carol R. Lizak serves as Executive at Jaguar Health, Inc., where they oversee executive responsibilities. Since joining the company, Carol R. Lizak has executed 8 insider transactions totaling $20.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 11, 2025 involved receiving (via award) 11,740 shares valued at $0.
Carol R. Lizak currently holds 11,911 shares of Jaguar Health, Inc. (JAGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carol R. Lizak has been a net buyer of JAGX stock. They have purchased $20.0K and sold $0 worth of shares.
Carol R. Lizak's most recent insider trade was on Dec 11, 2025, when they sold 11,740 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 5, 2024 | JAGX | $0 | Option Exercise | 60 | $N/A | Discretionary |
| Aug 14, 2023 | JAGX | $0 | Award | 142,088 | $N/A | Discretionary |
| May 17, 2023 | JAGX | $0 | Option Exercise | 431 | $N/A | Discretionary |
| Apr 5, 2023 | JAGX | $0 | Option Exercise | 60 | $N/A | Discretionary |
| Apr 5, 2022 | JAGX | $0 | Option Exercise | 4,513 | $N/A | Discretionary |
| Sep 13, 2021 | JAGX | $20.0K | Purchase | 7,968 | $2.51 | Discretionary |